News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
272,352 Results
Type
Article (14659)
Company Profile (305)
Press Release (257388)
Section
Business (81462)
Career Advice (164)
Deals (13655)
Drug Delivery (35)
Drug Development (51410)
Employer Resources (31)
FDA (6201)
Job Trends (5359)
News (148905)
Policy (10968)
Tag
Academia (937)
Alliances (22042)
Alzheimer's disease (779)
Approvals (6179)
Artificial intelligence (70)
Bankruptcy (125)
Best Places to Work (4743)
Biotechnology (249)
Breast cancer (109)
Cancer (895)
Cardiovascular disease (72)
Career advice (145)
CAR-T (73)
Cell therapy (217)
Clinical research (41095)
Collaboration (316)
Compensation (129)
COVID-19 (1065)
C-suite (78)
Cystic fibrosis (66)
Data (1002)
Diabetes (87)
Diagnostics (1247)
Drug discovery (57)
Earnings (30015)
Events (48268)
Executive appointments (253)
FDA (6583)
Funding (310)
Gene editing (63)
Gene therapy (164)
GLP-1 (314)
Government (1170)
Healthcare (6975)
Infectious disease (1103)
Inflammatory bowel disease (100)
IPO (7395)
Job creations (889)
Job search strategy (138)
Layoffs (195)
Legal (1764)
Lung cancer (132)
Lymphoma (63)
Manufacturing (87)
Medical device (3037)
Medtech (3038)
Mergers & acquisitions (6385)
Metabolic disorders (260)
Neuroscience (1027)
NextGen Class of 2024 (2145)
Non-profit (1016)
Northern California (1120)
Obesity (143)
Opinion (96)
Parkinson's disease (75)
Patents (64)
People (25495)
Phase I (14294)
Phase II (18957)
Phase III (12301)
Pipeline (373)
Postmarket research (941)
Preclinical (6009)
Radiopharmaceuticals (205)
Rare diseases (203)
Real estate (1450)
Regulatory (8772)
Research institute (955)
Southern California (1014)
Startups (1997)
United States (8930)
Vaccines (169)
Weight loss (85)
Date
Last 7 days (372)
Last 30 days (1456)
Last 365 days (21085)
2024 (20994)
2023 (22948)
2022 (27554)
2021 (28654)
2020 (24402)
2019 (17035)
2018 (12512)
2017 (14288)
2016 (12355)
2015 (14972)
2014 (10857)
2013 (7869)
2012 (7935)
2011 (8042)
2010 (7808)
Location
Africa (165)
Asia (17352)
Australia (2950)
California (2559)
Canada (828)
China (203)
Colorado (92)
Connecticut (103)
Europe (37433)
Florida (286)
Georgia (76)
Illinois (159)
Indiana (69)
Kansas (58)
Maryland (339)
Massachusetts (1974)
Minnesota (109)
New Jersey (666)
New York (691)
North Carolina (442)
Northern California (1120)
Ohio (88)
Pennsylvania (480)
South America (231)
Southern California (1014)
Texas (293)
Washington State (248)
272,352 Results for "relief therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
December 16, 2024
·
6 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
Business
Relief Therapeutics Announces Executive Changes - June 4, 2024
RELIEF THERAPEUTICS Holding SA today announced that interim Chief Executive Officer Michelle Lock has completed her transitional mandate with the Company.
June 3, 2024
·
2 min read
Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders
RELIEF THERAPEUTICS Holding SA announced the Annual General Meeting of shareholders will take place on Thursday, June 27, 2024, at 11:00 a.m. CEST at Campus Biotech, chemin des Mines 9, 1202 Geneva, Switzerland.
May 30, 2024
·
3 min read
Business
Relief Therapeutics has Published its Annual Report
RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, published its Annual Report 2023 and provided a corporate update.
April 30, 2024
·
2 min read
Press Releases
Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger
November 4, 2024
·
9 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of the extraordinary general meeting of shareholders, which took place in Geneva , Friday, April 26, 2024.
April 26, 2024
·
4 min read
Press Releases
Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
November 11, 2024
·
5 min read
Business
Logix Biosciences Enters into Agreement with Mayo Clinic to Advance Development of Therapeutics for Allergy Relief, Mutating Infectious Diseases and Antimicrobial Resistance
Logix Biosciences, a biopharmaceutical company focused on the discovery and development of a pipeline of precision therapeutics and companion diagnostics for allergy relief, protection against infectious diseases, and antimicrobial resistance (AMR), today announced it has entered into a know-how agreement with Mayo Clinic.
June 12, 2024
·
2 min read
Business
Relief Therapeutics Announces New Executive Leadership Team Strengthening Capabilities to Guide the Company through Pipeline Development Initiatives
RELIEF THERAPEUTICS Holding SA announced the formation of its new executive committee strengthening its capabilities with the appointment of several new members, including a chief financial officer, chief human resources officer and head of legal and compliance.
May 8, 2024
·
5 min read
1 of 27,236
Next
